At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

People who take Novo Nordisk's semaglutide-based injectables Ozempic and Wegovy seem to be way less likely to die from ...

The results of Novo Nordisk’s phase 1 trials shows the oral weight loss pill could be more effective than semaglutide.

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

Several other weight-loss pills are also in late-stage trials ... of safety and that we will continue to see the benefits that we’ve seen already with semaglutide, potentially even on a grander scale, ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

Experts said that while pills may be cheaper when compared to injectable drugs like semaglutide – of which there is a ...

Appetite suppressants: These pills work by reducing hunger and making you feel full longer. By curbing appetite, suppressants ...

About half or more patients taking semaglutide, a glucagon-like peptide ... their once-weekly subcutaneous injections or daily oral pills at 12 months, but longer-acting formulations may increase ...

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

The most advanced of these pills include a form of semaglutide, the active ingredient in Ozempic and Wegovy, being developed by Novo Nordisk. The Danish drugmaker reported last year that a late ...